Which option correctly identifies atropine as a muscarinic antagonist?

Which option correctly identifies atropine as a muscarinic antagonist?

• A. Atropine is a muscarinic receptor antagonist
• B. Atropine is a beta-adrenergic agonist
• C. Atropine is a nicotinic receptor antagonist
• D. Atropine is a GABA receptor agonist

Answer: (A)

Blocking muscarinic acetylcholine receptors is the key idea. Atropine works by binding to muscarinic receptors and preventing acetylcholine from activating them, making it a muscarinic antagonist. This produces the classic anticholinergic effects such as increased heart rate, reduced secretions, and pupil dilation. It does not act on beta-adrenergic receptors, so it isn’t a beta-adrenergic agonist. It also doesn’t block nicotinic receptors at the neuromuscular junction or in autonomic ganglia, nor does it act as a GABA receptor agonist. Therefore, identifying atropine as a muscarinic receptor antagonist is the correct characterization.

Blocking muscarinic acetylcholine receptors is the key idea. Atropine works by binding to muscarinic receptors and preventing acetylcholine from activating them, making it a muscarinic antagonist. This produces the classic anticholinergic effects such as increased heart rate, reduced secretions, and pupil dilation. It does not act on beta-adrenergic receptors, so it isn’t a beta-adrenergic agonist. It also doesn’t block nicotinic receptors at the neuromuscular junction or in autonomic ganglia, nor does it act as a GABA receptor agonist. Therefore, identifying atropine as a muscarinic receptor antagonist is the correct characterization.